Satellos Bioscience Inc
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy di… Read more
Market Cap & Net Worth: Satellos Bioscience Inc (MSCLF)
Satellos Bioscience Inc (OTCQB:MSCLF) has a market capitalization of $89.60 Million ($89.60 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #19399 globally and #7123 in its home market, demonstrating a -12.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Satellos Bioscience Inc's stock price $0.48 by its total outstanding shares 185507153 (185.51 Million).
Satellos Bioscience Inc Market Cap History: 2015 to 2025
Satellos Bioscience Inc's market capitalization history from 2015 to 2025. Data shows growth from $4.38 Million to $89.60 Million (26.83% CAGR).
Satellos Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Satellos Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MSCLF by Market Capitalization
Companies near Satellos Bioscience Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Satellos Bioscience Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Satellos Bioscience Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Satellos Bioscience Inc's market cap moved from $4.38 Million to $ 89.60 Million, with a yearly change of 26.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $89.60 Million | -5.16% |
| 2024 | $94.48 Million | +56.71% |
| 2023 | $60.29 Million | +88.95% |
| 2022 | $31.91 Million | -78.77% |
| 2021 | $150.26 Million | +1559.84% |
| 2020 | $9.05 Million | -7.05% |
| 2019 | $9.74 Million | +65.09% |
| 2018 | $5.90 Million | +6.00% |
| 2017 | $5.57 Million | -5.96% |
| 2016 | $5.92 Million | +35.17% |
| 2015 | $4.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Satellos Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $89.60 Million USD |
| MoneyControl | $89.60 Million USD |
| MarketWatch | $89.60 Million USD |
| marketcap.company | $89.60 Million USD |
| Reuters | $89.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.